Related Experiment Video
Updated: Jul 19, 2026

Invasive Hemodynamic Monitoring of Aortic and Pulmonary Artery Hemodynamics in a Large Animal Model of ARDS
Published on: November 26, 2018
Effects of digoxin on acute, atrial fibrillation-induced changes in atrial refractoriness
C Sticherling1, H Oral, J Horrocks
1Division of Cardiology, Department of Internal Medicine, University of Michigan Medical Center, Ann Arbor, MI 48109-0022, USA.
Background:
Atrial fibrillation (AF) shortens the atrial effective refractory period (ERP) and predisposes to further episodes of AF. The acute changes in atrial refractoriness may be related to tachycardia-induced intracellular calcium overload. The purpose of this study was to determine whether digoxin, which increases intracellular calcium, potentiates the acute effects of AF on atrial refractoriness in humans.
Methods And Results:
In 38 healthy adults, atrial ERP was measured at basic drive cycle lengths (BDCLs) of 350 and 500 ms after autonomic blockade. Nineteen patients had been treated with digoxin for 2 weeks. After a several-minute episode of AF, atrial ERP was measured serially at alternating BDCLs. Compared with pre-AF ERPs, the first post-AF ERPs were significantly shorter in both the digoxin and the control groups (P:<0.001). The post-AF ERP at a BDCL of 350 ms shortened to a greater degree in the digoxin group (37+/-16 ms) than in the control group (20+/-13 ms, P:<0.001); similar changes occurred at a BDCL of 500 ms. During post-AF determinations of the atrial ERP, secondary AF episodes occurred significantly more often in the digoxin group (32% versus 16%; P:<0. 04).
Conclusions:
After a brief episode of AF, digoxin augments the shortening that occurs in atrial refractoriness and predisposes to the reinduction of AF. These effects occur in the setting of autonomic blockade and therefore are more likely to be due to the effects of digoxin on intracellular calcium than to its vagotonic effects.
Insights
Digoxin worsens atrial refractoriness after atrial fibrillation (AF) episodes, increasing the risk of recurrent AF. This effect is likely due to digoxin
Area of Science:
- Cardiovascular Electrophysiology
- Cardiac Arrhythmias
- Pharmacology
Background:
- Atrial fibrillation (AF) shortens the atrial effective refractory period (ERP), increasing susceptibility to further AF episodes.
- Acute changes in atrial refractoriness may stem from tachycardia-induced intracellular calcium overload.
Purpose of the Study:
- To investigate if digoxin, a drug that increases intracellular calcium, potentiates the acute effects of AF on atrial refractoriness in humans.
Main Methods:
- Measured atrial ERP in 38 healthy adults after autonomic blockade, with 19 receiving digoxin treatment.
- Assessed atrial ERP at basic drive cycle lengths (BDCLs) of 350 and 500 ms before and after a brief AF episode.
- Compared post-AF ERP changes and incidence of secondary AF episodes between digoxin and control groups.
Main Results:
- Post-AF atrial ERP was significantly shorter in both groups compared to pre-AF values.
- The reduction in atrial ERP was significantly greater in the digoxin group than in the control group at both BDCLs.
- Secondary AF episodes occurred more frequently in the digoxin group (32%) compared to the control group (16%).
Conclusions:
- Digoxin augments the acute shortening of atrial refractoriness following AF episodes.
- This augmentation by digoxin predisposes patients to AF reinduction, independent of vagotonic effects.
- The findings suggest digoxin's effects on intracellular calcium contribute to its pro-arrhythmic potential in AF.
Related Concept Videos
Factors Influencing Heart Rate
Let us explore the significant factors affecting heart rate, including age, body temperature, posture, acute pain, chemical influences,...
Disturbances in Heart Rhythm
Arrhythmias are categorized by their speed, rhythm, and origin. A slow heart...
Measurement of Blood Pressure
Mitral Regurgitation I: Introduction
Introduction Cardiac Emergencies
Pulmonary Embolism I: Introduction

